Drugs / GGF2
GGF2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01944683 | Sep 2013 → May 2016 | heart failure | Acorda Therapeutics | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01258387 Comparator | Dec 2010 → Dec 2012 | heart failure | Acorda Therapeutics | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2008-08-06 | Zensun Sci. & Tech. Co., Ltd. | Results Effects of rhNRG-1 on Cardiac Function Improvements was Verified by the Recent Scientific Experiment zensun.com ↗
In Basic Cardiovascular Sciences Conference 2008, Acorda Therapeutics reported their new results of GGF2’s (glial growth factor 2, a full-length neuregulin) effects on cardiac function improvement. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2008-08-06 | Zensun Sci. & Tech. Co., Ltd. | Effects of rhNRG-1 on Cardiac Function Improvements was Verified by the Recent Scientific Experiment zensun.com ↗ |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GGF2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01944683 ↗ |
| Known as | Cimaglermina alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL3039542 ↗ |
| Known as | Cimaglermine alfa | ChEMBL registry synonym — accepted as the source's own label CHEMBL3039542 ↗ |
| Known as | Glial growth factor 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01258387 ↗ |
| Known as | Neuregulin 1β3 | “Glial growth factor 2/ Neuregulin 1β3” NCT01258387 ↗ |
| Known as | Neuroglia growth factor 2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3039542 ↗ |
| Known as | Recombinant Human Glial Growth Factor 2 | “Recombinant Human Glial Growth Factor 2” NCT01258387 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Human Glial Growth Factor 2” NCT01258387 ↗ |
| Route | Intravenous | “single intravenous administrations of GGF2” NCT01258387 ↗ |